- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2023
- 150 Pages
United States
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2018
- 195 Pages
Global
From €13647EUR$14,995USD£11,699GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Duavee is a brand of endocrine and metabolic disorder drugs used to treat menopausal symptoms, osteoporosis, and other conditions. It is a combination of conjugated estrogens and bazedoxifene, a selective estrogen receptor modulator (SERM). Duavee is used to reduce the risk of fractures and other bone-related problems in postmenopausal women. It is also used to treat hot flashes and other menopausal symptoms. Duavee is available in tablet form and is taken orally.
Duavee is a relatively new drug on the market, but it has been gaining traction in recent years. It is becoming increasingly popular among postmenopausal women due to its efficacy in treating menopausal symptoms and reducing the risk of fractures.
Some companies in the Duavee market include Pfizer, Merck, and Novartis. Show Less Read more